Menu
Washingtoner
  • Home
  • Financial
  • Technology
  • Non-profit
  • Boeing
  • Business
  • Services
  • Daryl Guberman
  • Education
Washingtoner

Lineus Medical Announces a Reduction in Price for SafeBreak Vascular
Washingtoner/10268034

Trending...
  • Spokane: Indian Canyon Golf Course Opens Thursday, March 12, 2026
  • The Media Should Protect the Public When It Comes to Boeing — But Does It?
  • The GUBERMAN Anomaly: Boeing's Alliance with ANSI–ANAB Exposed in Federal Contract 19AQMM18R0131
SafeBreak Vascular Lineus Medical
FAYETTEVILLE, Ark. - Washingtoner -- Lineus Medical announces a significant reduction in price of nearly 15% for its flagship product, SafeBreak Vascular, in the United States. After creating a new device classification with the FDA and becoming the first break-away device available for IV lines in the US, SafeBreak Vascular was first released with a list price of $6.90. Since its release, increased sales volume and concentrated efforts toward manufacturing efficiencies support a price adjustment with a new list price of $5.90, effective on September 1st, 2024.

SafeBreak Vascular is the only break-away device for IV lines proven to reduce IV complications1.  When a harmful force is placed on the line, SafeBreak intentionally separates to remove the damaging force and protect the patient's IV. When SafeBreak separates, valves on both ends of the device close preventing medicine spills from the pump and blood loss from the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile SafeBreak is installed, and the patent's infusion is restarted. Patients avoid additional needlesticks, nurses save time, and hospitals save money1.

More on Washingtoner
  • The "Unsexy" Business Quietly Creating 130+ New Entrepreneurs Across America — From Alaska to Puerto Rico
  • Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
  • City of Tacoma Elevates 28-Year South African Sister City Relationship to District-Wide Partnership
  • RecallSentry™ App Launch — Your Home Safety Hub — Free on iOS & Android
  • Award-Winning Director Crystal J. Huang's Under-$50K Film "The Ritual House" Wins Best Horror Feature at Golden State Film Festival

"A large focus of our strategy is maximizing our economic value proposition for the hospital." Lineus Medical's Vice President of Sales, Larry Hayes comments, "Reducing our price allows for both current and new accounts to take advantage of cost savings, and in doing so, we are making it easier for hospitals to invest in improved vascular access care for their patients."

Vance Clement, CEO of Lineus Medical, stated, "Inflation is hitting everyone, and we are all used to prices going up.  This is especially true in healthcare, where prices never go down. However, SafeBreak, which is proudly made in the USA, is changing that. As we continue to grow, we will keep investing in manufacturing so that we can lower the cost of SafeBreak again in the future."

Lineus Medical is committed to improving patient safety and advancing vascular access care and believes that this price reduction is another important step in our mission to remove the pains associated with medical lines.  Anyone interested in SafeBreak Vascular's price reduction can visit our website www.lineusmed.com to learn more.

About Lineus Medical

Lineus Medical is the developer of a break-away technology that is proven to reduce IV restarts and IV complications1. Our mission is to remove the pains associated with medical lines. More information about Lineus Medical can be found at www.lineusmed.com. Follow Lineus Medical on LinkedIn.

Contact
Vance Clement
***@lineusmed.com


Source: Lineus Medical

Show All News | Report Violation

0 Comments
1000 characters max.

Latest on Washingtoner
  • Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
  • Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
  • The Franchise King® Releases Free Guide for Nervous Buyers
  • The Unsweetened Tooth Declares the End of Sugar‑Spiked Cookies
  • Kanguro Insurance Taps Paylode to Launch Best-in-Class Pet and Renters Insurance Rewards Experience
  • CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
  • NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
  • Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth
  • Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
  • Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
  • Window Sticker Lookup By VIN Launches Free Direct OEM Monroney Label Lookups
  • Author Ken Mora to Celebrate New Caravaggio Book Debut with Special Event at Palazzo Venezia Naples
  • Matthew Sisneros Releases Raw and Unfiltered Memoir: The Devil Lost Another One — A Powerful Story of Crime, Consequence, and Redemption
  • From Life to Light: Jess L. Martinez Shares a Soulful Poetry Collection That Explores What It Means to Be Human
  • Lawsuit Filed Against Boeing Over Defective Seat Switch on Boeing 787
  • Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
  • Danholm Collection Announces Sale of 16689 Broadwater Ave in Winter Garden, Highlighting Strong Performance in Twinwaters Community
  • Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
  • 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced
  • Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
_catLbl0 _catLbl1

Popular on Washingtoner

  • OneVizion Announces Next Phase of Growth as Brad Kitchens Joins Board of Directors - 164
  • Still Using Ice? FrostSkin Reinvents Hydration - 112
  • Male In Custody After North Spokane Drive By Shooting
  • Spokane: 2026 Safe Streets For All (Traffic Calming) Updates
  • Cold. Clean. Anywhere. Meet FrostSkin
  • Tacoma: Applicants Sought for the Public Utility Board
  • Ice Melts. Infrastructure Fails. What Happens to Clean Water?
  • Spokane: Water Wise Wednesday Workshops Begin March 4
  • Tacoma City Council Announces City Manager Finalists
  • Primeindexer Google indexing platform launched by SEO Danmark APS

Similar on Washingtoner

  • Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
  • RecallSentry™ App Launch — Your Home Safety Hub — Free on iOS & Android
  • K2 Integrity Enhances Technology Capabilities Through Acquisition of Leviathan Security Group
  • Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
  • Kanguro Insurance Taps Paylode to Launch Best-in-Class Pet and Renters Insurance Rewards Experience
  • CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
  • NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
  • Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
  • Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
  • Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
Copyright © 2026 washingtoner.com | Terms of Service | Privacy Policy | Contact Us | Contribute